Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Christopher Martin, Keith Harris, Carol Wylie & Katherine Isoardi. (2023) Rising prescription stimulant poisoning in Australia: a retrospective case series. Toxicology Communications 7:1.
Read now
Read now
Sina Motamedi, Vahid Sheibani, Mohammad Amin Rajizadeh, Khadijeh Esmaeilpour & Gholamreza Sepehri. (2021) The effects of co-administration of marijuana and methylphenidate on spatial learning and memory in male rats. Toxin Reviews 40:4, pages 1094-1103.
Read now
Read now
Paloma Sales, Fiona Murphy, Sheigla Murphy & Nicholas Lau. (2019) Burning the candle at both ends: motivations for non-medical prescription stimulant use in the American workplace. Drugs: Education, Prevention and Policy 26:4, pages 301-308.
Read now
Read now
Caroline Robitaille & Johanne Collin. (2016) Prescription Psychostimulant Use Among Young Adults: A Narrative Review of Qualitative Studies. Substance Use & Misuse 51:3, pages 357-369.
Read now
Read now
Kenneth M Dürsteler, Eva-Maria Berger, Johannes Strasser, Carlo Caflisch, Jochen Mutschler, Marcus Herdener & Marc Vogel. (2015) Clinical potential of methylphenidate in the treatment of cocaine addiction: a review of the current evidence. Substance Abuse and Rehabilitation 6, pages 61-74.
Read now
Read now
Narong Maneeton, Benchalak Maneeton, Suthi Intaprasert & Pakapan Woottiluk. (2014) A systematic review of randomized controlled trials of bupropion versus methylphenidate in the treatment of attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment 10, pages 1439-1449.
Read now
Read now
Carlos Roncero & F Javier Álvarez. (2014) The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders. Expert Review of Neurotherapeutics 14:8, pages 849-865.
Read now
Read now
Articles from other publishers (23)
Christine Ramdin, Rama Bikkina, Lewis Nelson & Maryann Mazer-Amirshahi. (2023) Trends in amphetamine prescriptions given at discharge in emergency departments: A national analysis (2012–2019). The American Journal of Emergency Medicine 66, pages 91-97.
Crossref
Crossref
Shannon Brumbaugh, Wen Jan Tuan, Alyssa Scott, James R. Latronica & Curtis Bone. (2022) Trends in characteristics of the recipients of new prescription stimulants between years 2010 and 2020 in the United States: An observational cohort study. eClinicalMedicine 50, pages 101524.
Crossref
Crossref
Maria Perelló, Karla Rio-Aige, Rafel Guayta-Escolies, Pilar Gascón, Pilar Rius, Anna M. Jambrina, Guillermo Bagaria, Mercè Armelles, Francisco José Pérez-Cano & Manel Rabanal. (2021) Evaluation of Medicine Abuse Trends in Community Pharmacies: The Medicine Abuse Observatory (MAO) in a Region of Southern Europe. International Journal of Environmental Research and Public Health 18:15, pages 7818.
Crossref
Crossref
Gideon Koren & Liat Korn. (2021) The Use of Methylphenidate for Cognitive Enhancement in Young Healthy Adults. Journal of Clinical Psychopharmacology 41:2, pages 100-102.
Crossref
Crossref
Stephen V. Faraone, Anthony L. Rostain, C. Brendan Montano, Oren Mason, Kevin M. Antshel & Jeffrey H. Newcorn. (2020) Systematic Review: Nonmedical Use of Prescription Stimulants: Risk Factors, Outcomes, and Risk Reduction Strategies. Journal of the American Academy of Child & Adolescent Psychiatry 59:1, pages 100-112.
Crossref
Crossref
Shann Hulme, David Bright & Suzanne Nielsen. (2018) The source and diversion of pharmaceutical drugs for non-medical use: A systematic review and meta-analysis. Drug and Alcohol Dependence 186, pages 242-256.
Crossref
Crossref
Fiona Murphy, Sheigla Murphy, Paloma Sales & Nicholas Lau. (2018) Examining social supply among nonmedical prescription stimulant users in the San Francisco Bay Area. International Journal of Drug Policy 54, pages 68-76.
Crossref
Crossref
Melissa M. Ross, Amelia M. Arria, Jessica P. Brown, C. Daniel Mullins, Jason Schiffman, Linda Simoni-Wastila & Susan dosReis. (2018) College students' perceived benefit-to-risk tradeoffs for nonmedical use of prescription stimulants: Implications for intervention designs. Addictive Behaviors 79, pages 45-51.
Crossref
Crossref
Caline S. Karam & Jonathan A. Javitch. 2018. Apprentices to Genius: A tribute to Solomon H. Snyder. Apprentices to Genius: A tribute to Solomon H. Snyder
205
234
.
Jadwiga Najib, Dexter WimerJulie ZengKristina W LamNatalya RomanyakEva Paige MorganAnu Thadavila. (2017) Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder. Journal of Central Nervous System Disease 9, pages 117957351772809.
Crossref
Crossref
Khyati Brahmbhatt, Donald M. Hilty, Mina Hah, Jaesu Han, Kathy Angkustsiri & Julie B. Schweitzer. (2016) Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder During Adolescence in the Primary Care Setting: A Concise Review. Journal of Adolescent Health 59:2, pages 135-143.
Crossref
Crossref
Timothy J. Wiegand, Marie-Claire Le Lait, Becki Bucher Bartelson, Richard C. Dart & Jody L. Green. (2016) Analysis of the Abuse and Diversion of the Buprenorphine Transdermal Delivery System. The Journal of Pain 17:6, pages 745-752.
Crossref
Crossref
Rose Cairns, Benjamin Daniels, Danielle A Wood & Jonathan Brett. (2016) ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004–2014. Medical Journal of Australia 204:4, pages 154-154.
Crossref
Crossref
Eric L. Sevigny & Brian Fuleihan. 2015. The Handbook of Drugs and Society. The Handbook of Drugs and Society
258
281
.
Sherry A. Ferguson, C. Delbert Law, Leyla Sahin & Susan V. Montenegro. (2015) Effects of perinatal methylphenidate (MPH) treatment on postweaning behaviors of male and female Sprague–Dawley rats. Neurotoxicology and Teratology 47, pages 125-136.
Crossref
Crossref
Scott H. Kollins, Erin N. Schoenfelder, Joseph S. English, Alex Holdaway, Elizabeth Van Voorhees, Benjamin R. O’Brien, Rachel Dew & Allan K. Chrisman. (2015) An exploratory study of the combined effects of orally administered methylphenidate and delta-9-tetrahydrocannabinol (THC) on cardiovascular function, subjective effects, and performance in healthy adults. Journal of Substance Abuse Treatment 48:1, pages 96-103.
Crossref
Crossref
Suzanne K. Vosburg & Marta Sokolowska. 2015. Nonclinical Assessment of Abuse Potential for New Pharmaceuticals. Nonclinical Assessment of Abuse Potential for New Pharmaceuticals
215
243
.
Karen K. Gerlach, Nabarun Dasgupta, Sidney H. Schnoll & Jack E. Henningfield. (2014) Epidemiology of stimulant misuse and abuse: Implications for future epidemiologic and neuropharmacologic research. Neuropharmacology 87, pages 91-96.
Crossref
Crossref
Karran A. Phillips, David H. Epstein & Kenzie L. Preston. (2014) Psychostimulant addiction treatment. Neuropharmacology 87, pages 150-160.
Crossref
Crossref
Kennerly S. Patrick, Timothy R. Corbin & Cristina E. Murphy. (2014) Ethylphenidate as a Selective Dopaminergic Agonist and Methylphenidate–Ethanol Transesterification Biomarker. Journal of Pharmaceutical Sciences 103:12, pages 3834-3842.
Crossref
Crossref
Erin S. Calipari & Sara R. Jones. (2014) Sensitized nucleus accumbens dopamine terminal responses to methylphenidate and dopamine transporter releasers after intermittent-access self-administration. Neuropharmacology 82, pages 1-10.
Crossref
Crossref
David R. Coghill, Beatriz Caballero, Shaw Sorooshian & Richard Civil. (2014) A Systematic Review of the Safety of Lisdexamfetamine Dimesylate. CNS Drugs 28:6, pages 497-511.
Crossref
Crossref
WooChan Kim, Amane Tateno, Ryosuke Arakawa, Takeshi Sakayori, Yumiko Ikeda, Hidenori Suzuki & Yoshiro Okubo. (2014) In vivo activity of modafinil on dopamine transporter measured with positron emission tomography and [18F]FE-PE2I. The International Journal of Neuropsychopharmacology 17:05, pages 697-703.
Crossref
Crossref